4//SEC Filing
Schranz Jennifer 4
Accession 0001104659-21-011104
CIK 0001641640other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:00 PM ET
Size
6.0 KB
Accession
0001104659-21-011104
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2021-01-29+22,500→ 39,194 total - Tax Payment
Ordinary Shares
2021-01-31$2.62/sh−36$94→ 39,158 total
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001735382
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:00 PM ET
- Size
- 6.0 KB